Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
US and Iran clash over uranium enrichment as...
Hundreds of Ukrainian prisoners released in swap with...
Trump signs executive orders bolstering nuclear industry, domestic...
Trump administration plans to overhaul National Security Council,...
Satellite images reveal North Korea’s mangled naval destroyer...
Trump admin steps up overhaul of National Security...
Trump unleashes US nuclear renaissance with bold executive...
DAVID MARCUS: Tax-free overtime could be midterm magic...
SCOOP: House Republicans request ban on federally funded...
WATCH: GOP senators rail against staggering $4.7 trillion...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Business

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

by admin May 2, 2025
May 2, 2025
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development. 

Bourla’s remarks on the company’s first-quarter earnings call came in response to a question about what Pfizer wants to see from tariff negotiations that would push the company to increase investments in the U.S. It comes as drugmakers brace for Trump’s levies on pharmaceuticals imported into the country — his administration’s bid to boost domestic manufacturing.

“If I know that there will not be tariffs … then there are tremendous investments that can happen in this country, both in R&D and manufacturing,” Bourla said on the call, adding that the company is also hoping for “certainty.”

“In periods of uncertainty, everybody is controlling their cost as we are doing, and then is very frugal with their investment, as we are doing, so that we are prepared for remit. So that’s what I want to see,” Bourla said.

Bourla noted the tax environment, which had previously pushed manufacturing abroad, has “significantly changed now” with the establishment of a global minimum tax of around 15%. He said that shift hasn’t necessarily made the U.S. more attractive, saying “it’s not as good” to invest here without additional incentives or clarity around tariffs.

“Now [Trump] I’m sure — and I know because I talked to him — that he would like to see even a reduction in the current tax regime particularly for locally produced goods,” Bourla said, adding a further decrease would be would be a strong incentive for manufacturing in the U.S.

Unlike other companies grappling with evolving trade policy, Pfizer did not revise its full-year outlook on Tuesday. However, the company noted in its earnings release that the guidance “does not currently include any potential impact related to future tariffs and trade policy changes, which we are unable to predict at this time.”

But on the earnings call on Tuesday, Pfizer executives said the guidance does reflect $150 million in costs from Trump’s existing tariffs.

“Included in our guidance that we didn’t really speak about is there are some tariffs in place today,” Pfizer CFO Dave Denton said on the call.

“We are contemplating that within our guidance range and we continue to again trend to the top end of our guidance range even with those costs to be incurred this year,” he said.

This post appeared first on NBC NEWS

previous post
Nvidia says Anthropic is telling ‘tall tale’ in its defense of U.S. AI chip restrictions on China
next post
Crypto Market Recap: Trump’s US$2B Stablecoin Deal with UAE Sparks Ethics Debate

You may also like

Darden Restaurants sales disappoint as Olive Garden, LongHorn...

March 21, 2025

U.S. lawmakers move to ban China’s DeepSeek from...

February 7, 2025

Amazon’s $4 billion investment in AI firm Anthropic...

August 9, 2024

Millennials reimagine retirement: ‘The end game might not...

February 5, 2025

Sports gambling takes a toll on Americans’ checkbooks,...

August 27, 2024

ESPN hopes to reach more casual sports fans...

December 6, 2024

Why Chappell Roan and other artists find themselves...

February 9, 2025

Goldman Sachs rolls out an AI assistant for...

January 23, 2025

As Joann Fabrics and JCPenney announce store closings,...

February 18, 2025

The first Fed interest rate cut in years...

July 31, 2024

Recent Posts

  • US and Iran clash over uranium enrichment as nuclear talks resume in Rome
  • Hundreds of Ukrainian prisoners released in swap with Russia, Zelenskyy says
  • Trump signs executive orders bolstering nuclear industry, domestic uranium mining
  • Trump administration plans to overhaul National Security Council, weeks after Waltz’s departure
  • Satellite images reveal North Korea’s mangled naval destroyer after failed launch

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (742)
    • Investing (2,168)
    • Politics (2,688)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.